These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24305110)

  • 1. Impregnated central venous catheters should be readily used to reduce risk of bloodstream infection.
    Gilbert R; Harron K; Mok Q; Gamble C
    BMJ; 2013 Dec; 347():f7169. PubMed ID: 24305110
    [No Abstract]   [Full Text] [Related]  

  • 2. Central venous catheters.
    Smith RN; Nolan JP
    BMJ; 2013 Nov; 347():f6570. PubMed ID: 24217269
    [No Abstract]   [Full Text] [Related]  

  • 3. Question 3. Do Portacaths or Hickman lines have a higher risk of catheter-related bloodstream infections in children with leukaemia?
    Alexander N
    Arch Dis Child; 2010 Mar; 95(3):239-41. PubMed ID: 20308343
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of infections and complications in central venous catheters in adults with solid tumours.
    Coady K; Ali M; Sidloff D; Kenningham RR; Ahmed S
    J Vasc Access; 2015; 16(1):38-41. PubMed ID: 25198809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Can the Complications of Central Vein Catheters Be Reduced?: Preventing Common Complications of Central Vein Catheters.
    Anwar S; Vachharajani TJ
    Semin Dial; 2016 May; 29(3):189-91. PubMed ID: 26896644
    [No Abstract]   [Full Text] [Related]  

  • 6. How Can the Complications of Central Vein Catheters Be Reduced?: From Barrier Protection to Showering: Extraluminal Prophylaxis and Management of Catheter Infections.
    Lee T; Lok CE
    Semin Dial; 2016 May; 29(3):194-6. PubMed ID: 26896759
    [No Abstract]   [Full Text] [Related]  

  • 7. How Can the Complications of Central Vein Catheters Be Reduced?: Intraluminal Prophylaxis and Management of Catheter Infections: Role of Antibiotic Locks.
    Polkinghorne KR
    Semin Dial; 2016 May; 29(3):197-8. PubMed ID: 26875584
    [No Abstract]   [Full Text] [Related]  

  • 8. Portacaths.
    West HJ; Jin JO
    JAMA Oncol; 2016 Jan; 2(1):152. PubMed ID: 26720752
    [No Abstract]   [Full Text] [Related]  

  • 9. The risk of catheter-related bloodstream infection with femoral venous catheters as compared to subclavian and internal jugular venous catheters: a systematic review of the literature and meta-analysis.
    Marik PE; Flemmer M; Harrison W
    Crit Care Med; 2012 Aug; 40(8):2479-85. PubMed ID: 22809915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable Central Venous Access Ports Placed in Mastectomy Incision Sites: A Safe and Viable Option.
    Kajese TM; Drake RM; Ball J; Helmer SD; Osland JS
    Am Surg; 2016 Dec; 82(12):e341-343. PubMed ID: 28234163
    [No Abstract]   [Full Text] [Related]  

  • 11. Understanding percutaneous and subcutaneous central venous access devices.
    Luckianow GM; Smith D; Bullen D; Kaplan LJ
    JAAPA; 2016 Jan; 29(1):33-6. PubMed ID: 26704651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. We still go for the jugular: implications of the 3SITES central venous catheter study for nephrology.
    Wyatt CM; Vassalotti JA
    Kidney Int; 2016 Mar; 89(3):522-4. PubMed ID: 26880443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of central line-associated bloodstream infections in the intensive care unit after implementation of central line bundles.
    Shuman EK; Washer LL; Arndt JL; Zalewski CA; Hyzy RC; Napolitano LM; Chenoweth CE
    Infect Control Hosp Epidemiol; 2010 May; 31(5):551-3. PubMed ID: 20334506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Traditional Long-Term Central Venous Catheters Versus Transhepatic Venous Catheters in Infants and Young Children.
    Marshall AM; Danford DA; Curzon CL; Anderson V; Delaney JW
    Pediatr Crit Care Med; 2017 Oct; 18(10):944-948. PubMed ID: 28746169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pantoea agglomerans as a rare cause of catheter-related infection in hemodialysis patients.
    Wong KW
    J Vasc Access; 2013; 14(3):306. PubMed ID: 23599132
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term intravenous devices: a narrative review of their placement.
    Roche S
    Curr Opin Anaesthesiol; 2024 Aug; 37(4):400-405. PubMed ID: 38841917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial.
    Hanna H; Benjamin R; Chatzinikolaou I; Alakech B; Richardson D; Mansfield P; Dvorak T; Munsell MF; Darouiche R; Kantarjian H; Raad I
    J Clin Oncol; 2004 Aug; 22(15):3163-71. PubMed ID: 15284269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of a protocol for the prevention of hemodialysis venous catheter-related infections.
    Cornacchiari M; Heidempergher M; Stasi A; Baroli A; Bertoncini L; Turri C; Bellotti N; Guastoni C
    J Vasc Access; 2011; 12(4):313-7. PubMed ID: 21534231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malposition of Central Venous Catheter: Presentation and Management.
    Wang L; Liu ZS; Wang CA
    Chin Med J (Engl); 2016 Jan; 129(2):227-34. PubMed ID: 26830995
    [No Abstract]   [Full Text] [Related]  

  • 20. Current definitions of central line-associated bloodstream infection: is the emperor wearing clothes?
    Sexton DJ; Chen LF; Anderson DJ
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1286-9. PubMed ID: 20979492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.